Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoer Ma Long Zhike Pingchuan Granules in Pediatric Cough Variant Asthma
CTR20182313Phase 2Completed
- Sponsor
- Hainan Gourd Doll Pharmaceutical Group
- Start
- Nov 2019
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of xiaoer ma-long-zhi-ke-ping-chuan in cough variant asthma (CVA), asthma, sponsored by Hainan Gourd Doll Pharmaceutical Group. Started Nov 2019; status: completed.
02
Drugs
xiaoer ma-long-zhi-ke-ping-chuan
03
Conditions
cough variant asthma (CVA)asthma
Beyond the preview
Go deeper on CTR20182313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182313.